Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) will report its first quarter 2026 financial results on Monday, May 4, 2026, after the financial markets close. The company will host a conference ...

Vertex, Inc. (NASDAQ:VERX) is one of the 10 Beaten Down Stocks Insiders Are Piling Into. On March 17, 2026, Vertex, Inc.

Vertex Pharmaceuticals has seen impressive growth, with shares increasing by 14% and returning over 50% in the past year. The company's strong portfolio and pipeline have contributed to its consistent ...

Vertex Pharma has upside potential with a high-end fair value estimate of $481 per share. The company's cash-rich balance sheet and strong free cash flow generation reduce overall equity risk compared ...

With Vertex Pharmaceuticals (NASDAQ: VRTX) announcing on June 21 that its therapy VX-880 helped nearly all of the patients with diabetes in a clinical trial to reduce or eliminate their need for other ...

Vertex Pharmaceuticals (VRTX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to ...

(Bloomberg) -- Vertex Pharmaceuticals Inc. reported third-quarter sales that beat analysts’ expectations as the biotech company’s mainstay cystic fibrosis treatment saw revenue growth, even as new ...

Vertex just won approval for a drug to treat one of the most common health problems -- pain. The biotech company is offering an option for patients and doctors who don’t want to go for controversial ...

BO has agreed to purchase Vertex's marine fuel production at fair market transfer prices. Under the agreement, BO will purchase marine fuel from Vertex at a negotiated price correlated to Platts-based ...

Over half of CEOs globally are experimenting with AI to generate text, images and other forms of data, a recent joint survey by Fortune and Deloitte found. Meanwhile, a third of organizations are ...